Skip to main content

Table 4 Microbiologic documentation available in visit 2 in modified intention-to-treat patients with nosocomial pneumonia

From: Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study

 

Prior antibiotic therapy

Overall

Percentage performed

Chi-square P value

 

No

Yes

   

Pathogens (%)

    

0.002

   None

27.5

51.8

52.5

  

   Monomicrobial

33.3

29.0

29.9

  

   Polymicrobial

39.2

19.2

23.8

  

Yield of microbial investigations (%)

     

   Tracheal aspirate

87.5

79.5

81.4

81.6

 

   Protected specimen brush

96.3

67.9

80.0

32.8

 

   Bronchoalveolar lavage

100

71.4

77.5

4.1

 

Pathogens identified (all patients)

     

   Monomicrobial

17

56

73

 

0.02

Pseudomonas aeruginosa

1

13

14

  

Other Pseudomonas

0

2

2

  

Acinetobacter baumannii

0

11

11

  

Other Acinetobacter

0

1

1

  

Enterobacteriaceae

3

12

15

  

Staphylococcus aureus

4

9

13

  

Haemophylus influenzae

6

5

11

  

Streptococcus pneumoniae

2

2

4

  

Streptococcus viridans group

0

0

0

  

Other

1

1

2

  

   Polymicrobial

20

38

58

 

<0.001

Mixed, including NFGNB and methicillin-resistant S. aureus

4

23

27

  

H. influenzae plus Streptococcus spp.

9

2

11

  

Other

7

13

20

  

Pathogens identified (Group Va)

     

   Monomicrobial

1

7

8

  

P. aeruginosa

1

2

3

  

Other NFGNB

0

2

2

  

Enterobacteriaceae

0

1

1

  

Methicillin-resistant S. aureus

0

1

1

  

Other

0

1

1

  

   Polymicrobial

4

11

15

  

Mixed, including NFGNB and methicillin-resistant S. aureus

1

8

9

  

Other

3

3

6

  
  1. NFGNB, nonfermenting Gram-negative bacilli. Overall, there were 33 Pseudomonas isolates, including 30 Pseudomonas aeruginosa, two Pseudomonas putida, and one Pseudomonas spp., and 22 Acinetobacter isolates, including 20 A. baumannii, one Acinetobacter haemolyticus, and one Acinetobacter calcoaceticus. aGroup V, patients who initially received inadequate antibiotic therapy, which was later modified on the basis of cultures.